Jeena Sikho Lifecare Limited has submitted a regulatory disclosure to the National Stock Exchange of India Limited and BSE Limited pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015. The disclosure informs about the publication of case studies authored by the company's research officers and professionals, including the Managing Director, senior consultants, and Ayurvedic experts.
The case studies have been published in the "International Journal of Advanced Research (IJAR)" and demonstrate the company's commitment to Ayurvedic research and evidence-based clinical practice.
Details of Published Case Studies
- First Case Study: "Ayurvedic Management of Chronic Kidney Disease (Vrikka Vikara) with Reference to Mutravah Sroto Dushti: A Case Study" - Published at: https://www.journalijar.com/article/60358/ayurvedic-management-of-chronic-kidney-disease-vrikka-vikara-with-reference-to-mutravah-sroto-dushti-a-case-study/
- Second Case Study: "Role of Ayurveda in The Management of Vrikka Vikar (Kidney Disorders): A Case Study" - Published at: https://www.journalijar.com/article/60369/role-of-ayurveda-in-the-management-of-vrikka-vikar-kidney-disorders-a-case-study/
Additional Information
The information has been made available on the company's website at www.jeenasikho.com.
The disclosure is signed by Manish Grover, Managing Director (DIN: 07557886), and is dated 20th July, 2026 from Zirakpur, Punjab.